There were 579 press releases posted in the last 24 hours and 401,219 in the last 365 days.

Cell Isolation Market is Expected to Reach US$ 24.6 Billion by 2027 – IMARC Group

The global cell isolation market size reached US$ 10.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2027.

SHERIDAN, WYOMING, UNITED STATES, November 21, 2022 /EINPresswire.com/ -- According to the latest report by IMARC Group “Cell Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global cell isolation market size reached US$ 10.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2027, exhibiting a growth rate (CAGR) of 15.65% during 2022-2027.

Cell isolation, also known as cell separation, identifies, isolates and separates targeted cells from a heterogeneous mixture of a cell population. This process helps minimize experimental complexity, reduce the interference from other cell types, and diagnose diseases, cellular research and therapies. In recent years, cell separation has gained prominence as it plays a vital role in therapeutic protein production, in-vitro diagnostics and biologics designing.

Request for a free sample copy of this report: https://www.imarcgroup.com/cell-isolation-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The global cell isolation market is primarily driven by the expanding medical and pharmaceutical industry. Due to this, pharmaceutical manufacturers are using cell isolation technologies to develop drugs with improved efficacies. In addition, they are utilized to develop novel cell therapies and cell-based treatments for various chronic medical ailments. Besides this, with the onset of coronavirus disease (COVID-19), there has been rapid development of novel vaccines, therapies, and testing kits. This has escalated the demand for cell isolation tools for diagnostics and research activities. Moreover, increasing investments in research and development (R&D) by biotechnology and biopharmaceutical companies to manufacture advanced biologics,such as monoclonal antibodies and vaccines, provide a positive outlook to the market in the near future.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cell isolation market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technique, cell type, product, application and end use.

Breakup by Technique:

Centrifugation
Surface Marker
Filtration

Breakup by Cell Type:

Human Cells
Animal Cells

Breakup by Product:

Consumables
Reagents, Kits, Media and Sera
Beads
Disposables
Instruments
Centrifuges
Flow Cytometers
Filtration Systems
Magnetic-activated Cell Separator Systems

Breakup by Application:

Biomolecule Isolation
Therapeutics
Stem Cell Research
Cancer Research
Tissue Regeneration
In-Vitro Diagnostics

Breakup by End Use:

Biotechnology and Biopharmaceutical Companies
Hospitals and Diagnostic Laboratories
Research Laboratories and Institutes
Others

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape with Key Player:

Alfa Laval AB
Becton Dickinson and Company
Beckman Coulter Inc. (Danaher Corporation)
Bio-Rad Laboratories Inc.
General Electric Company
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
Roche Holding AG
STEMCELL Technologies Inc.
Terumo Corporation
Thermo Fisher Scientific Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: http://bit.ly/3kehYOq

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel NoD) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.